TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan · Delayed Price · Currency is TWD 11.85
-0.40 (-3.27%)
Mar 4, 2026, 10:19 AM CST
TPEX:4157 Market Cap
TPEX:4157 has a market cap or net worth of 8.72 billion as of March 3, 2026. Its market cap has increased by 11.44% in one year.
Market Cap
8.72B
Enterprise Value
7.94B
Revenue
38.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.85
Market Cap Chart
Since September 5, 2013, TPEX:4157's market cap has decreased from 42.07B to 8.72B, a decrease of -79.27%. That is a compound annual growth rate of -11.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 8.72B | -8.58% |
| Dec 31, 2025 | 9.54B | 16.05% |
| Dec 31, 2024 | 8.22B | -24.67% |
| Dec 29, 2023 | 10.91B | -5.16% |
| Dec 30, 2022 | 11.51B | 4.22% |
| Dec 30, 2021 | 11.04B | -32.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ever Supreme Bio Technology | 12.75B |
| Tanvex BioPharma | 12.63B |
| TCM Biotech International | 12.37B |
| Medigen Vaccine Biologics | 11.72B |
| Gongwin Biopharm Holdings | 9.91B |
| PharmaEngine | 9.02B |
| Acepodia | 7.66B |
| Adimmune | 7.50B |